Intest Res > v.23(4)

19 results

391 Gallstone burden and risk in Korean patients with ulcerative colitis
Seong Ran Jeon
KMSID: 1516094017   Intest Res. 2025;23(4):391-393.   Published online 2025 October 28    DOI: http://dx.doi.org/10.5217/ir.2025.00197
      
394 Three Janus kinase inhibitors in ulcerative colitis: is upadacitinib taking the lead?
Yoon Suk Jung
KMSID: 1516094015   Intest Res. 2025;23(4):394-395.   Published online 2025 October 28    DOI: http://dx.doi.org/10.5217/ir.2025.00166
      
396 Targeting the gut microbiome in inflammatory bowel disease: from concept to clinical reality
Nathalie Rolhion, Harry Sokol
KMSID: 1516094011   Intest Res. 2025;23(4):396-404.   Published online 2025 October 28    DOI: http://dx.doi.org/10.5217/ir.2025.00104
      
405 Asian–Pacific perspectives on the management of very early-onset inflammatory bowel disease
Ichiro Takeuchi, Katsuhiro Arai, Pornthep Tanpowpong, Ming-Wei Lai, Andrew S Day, Way Seah Lee, James Guoxian Huang, Karen Sophia Calixto-Mercado, Rosanna Ming Sum Wong, Muhammad Arshad Alvi, Zubin Grover, Jung Ok Shim, Ujjal Poddar
KMSID: 1516094009   Intest Res. 2025;23(4):405-429.   Published online 2025 October 28    DOI: http://dx.doi.org/10.5217/ir.2025.00082
      
430 Elderly-onset inflammatory bowel disease in Asia: clinical characteristics and therapeutic strategies
Jiyoung Yoon, Daein Kim, You Sun Kim
KMSID: 1516094020   Intest Res. 2025;23(4):430-442.   Published online 2025 October 28    DOI: http://dx.doi.org/10.5217/ir.2025.00221
      
443 Balancing safety and effectiveness in colonoscopy for older adults: a narrative review
Min-Jae Kim, Yuna Kim, Jie-Hyun Kim, Young Hoon Youn, Jaeyoung Chun
KMSID: 1516094010   Intest Res. 2025;23(4):443-454.   Published online 2025 October 2    DOI: http://dx.doi.org/10.5217/ir.2025.00092
      
455 Prevalence and risk factors of gallstone disease in Korean patients with ulcerative colitis
Kwangwoo Nam, Jae Yong Lee, Sang Hyoung Park, Ha Won Hwang, Ho-Su Lee, Kyunghwan Oh, Hee Seung Hong, Kyuwon Kim, Jin Hwa Park, Seung Wook Hong, Sung Wook Hwang, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang
KMSID: 1516094003   Intest Res. 2025;23(4):455-463.   Published online 2024 November 29    DOI: http://dx.doi.org/10.5217/ir.2024.00070
      
464 Propensity score-matched real-world comparative treatment outcomes of Janus kinase inhibitors for ulcerative colitis in patients with and without prior exposure to anti-tumor necrosis factor α antibody
Maiko Ikenouchi, Hirokazu Fukui, Soichi Yagi, Akira Nogami, Koji Kaku, Toshiyuki Sato, Mikio Kawai, Koji Kamikozuru, Yoko Yokoyama, Tetsuya Takagawa, Toshihiko Tomita, Taku Kobayashi, Shinichiro Shinzaki
KMSID: 1516094002   Intest Res. 2025;23(4):464-474.   Published online 2025 February 3    DOI: http://dx.doi.org/10.5217/ir.2024.00148
      
475 Upadacitinib and vedolizumab combination therapy for the management of refractory ulcerative colitis and Crohn’s disease
Robert Gilmore, Amrutha Murali, Amirah Etchegaray, Ei Swe, Yoon-Kyo An, Jakob Begun
KMSID: 1516094005   Intest Res. 2025;23(4):475-482.   Published online 2025 June 9    DOI: http://dx.doi.org/10.5217/ir.2024.00174
      
483 A real-world comparison of subcutaneous to intravenous administration of infliximab in patients with inflammatory bowel disease
Kwang Woo Kim, Hyoun Woo Kang, Seong-Joon Koh, Hyuk Yoon, Sihyun Kim, Yukyung Jun, Hyun Jung Lee, Jong Pil Im, Young Soo Park, Ji Won Kim, Joo Sung Kim
KMSID: 1516094007   Intest Res. 2025;23(4):483-490.   Published online 2025 June 23    DOI: http://dx.doi.org/10.5217/ir.2025.00001
      
491 Practices and perceptions of 5-aminosalicylic acid use in Crohn’s disease: a nationwide survey of physicians in Korea by KASID Guidelines Taskforce Team
June Hwa Bae, Seung Yong Shin, Dong Hyun Kim, Seung Min Hong, Eun Mi Song, Ji Eun Kim, Young Joo Yang, Jiyoung Yoon, Sang-Bum Kang, Eun Soo Kim, Sung Eun Kim, Seong-Jung Kim, Jun Lee, Soo-Young Na, Soo Jung Park, Sang Hyoung Park, Won Moon, Sung-Ae Jung
KMSID: 1516094019   Intest Res. 2025;23(4):491-501.   Published online 2025 October 28    DOI: http://dx.doi.org/10.5217/ir.2025.00211
      
502 Restoration of colonic barrier function by tofacitinib in experimental colitis: anti-inflammatory effects and decreased expression of claudins-2 and claudin-15
Humberto Barbosa da Costa Filho, Gerardo Autran Cavalcante Araújo, Thiago Meneses Araújo Leite Sales, Suliana Mesquita Paula, Marco Antonio de Freitas Clementino, Alexandre Havt, Pedro Marcos Gomes Soares, Marcellus Henrique Loiola Ponte Souza
KMSID: 1516094008   Intest Res. 2025;23(4):502-511.   Published online 2025 March 31    DOI: http://dx.doi.org/10.5217/ir.2024.00186
      
512 Knowledge and acceptability of the Lémann Index as a tool to measure disease progression and bowel damage in Crohn’s disease: results from an international survey
Charlotte Wong, Johan Burisch, Ryan C Ungaro, Anthony Buisson, Jérôme Lambert, Jean-Frédéric Colombel, Joana Torres, Naila Arebi
KMSID: 1516094006   Intest Res. 2025;23(4):512-523.   Published online 2025 October 28    DOI: http://dx.doi.org/10.5217/ir.2024.00183
      
524 Health-related quality of life, work productivity, and persisting challenges in treated ulcerative colitis patients: a Japanese National Health and Wellness Survey
Sakiko Hiraoka, Zhezhou Huang, Fei Qin, Fatima Megala Nathan Arokianathan, Kiran Davé, Shweta Shah, Hyunchung Kim
KMSID: 1516094004   Intest Res. 2025;23(4):524-540.   Published online 2025 January 2    DOI: http://dx.doi.org/10.5217/ir.2024.00104
      
541 Latent tuberculosis infection screening in patients with inflammatory bowel disease: a nationwide retrospective cohort study in South Korea comparing IGRA alone versus a combination of TST and IGRA
Ye-Jee Kim, Jiyeon Kim, Jiwon Lee, Tae Sun Shim, Sang Hyoung Park, Kyung-Wook Jo
KMSID: 1516094012   Intest Res. 2025;23(4):541-550.   Published online 2025 October 14    DOI: http://dx.doi.org/10.5217/ir.2025.00136
      
551 The impact of the quality improvement program on Clostridioides difficile infection management: a quasi-experimental study
Jung Yun Lee, Jae-Ki Choi, Tae-Geun Gweon, Young Eun An, Hyo Suk Kim, Jae Hyuck Chang, Tae Ho Kim, Chang Whan Kim, Young-Seok Cho
KMSID: 1516094013   Intest Res. 2025;23(4):551-558.   Published online 2025 October 28    DOI: http://dx.doi.org/10.5217/ir.2025.00137
      
559 Elevated IL-6 levels in the intestinal mucosa of patients with gastrointestinal Behçet’s disease
Jihye Park, Arjun Ravi, Katharina Bruzelius, I Seul Park, Philippe Pinton, Jae Hee Cheon
KMSID: 1516094014   Intest Res. 2025;23(4):559-564.   Published online 2025 October 28    DOI: http://dx.doi.org/10.5217/ir.2025.00154
      
565 Comments on “Role of 5-aminosalicylic acid in ulcerative colitis management in 8 Asian territories: a physician survey”
Tsutomu Nishida, Takahiro Amano, Naoto Osugi, Takeo Yoshihara
KMSID: 1516094016   Intest Res. 2025;23(4):565-566.   Published online 2025 October 28    DOI: http://dx.doi.org/10.5217/ir.2025.00158
      
567 Response: Comments on “Role of 5-aminosalicylic acid in ulcerative colitis management in 8 Asian territories: a physician survey”
Julajak Limsrivilai, Wai Keung Leung
KMSID: 1516094018   Intest Res. 2025;23(4):567-568.   Published online 2025 October 28    DOI: http://dx.doi.org/10.5217/ir.2025.00202
      
Articles from Intestinal Research are provided here courtesy of Korean Association for the Study of Intestinal Diseases